已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

Hypertension burden and control in mainland China: Analysis of nationwide data 2003–2012

医学 中国大陆 中国 梅德林 环境卫生 政治学 法学
作者
Dianjiang Li,Jun Lv,Fangchao Liu,Pei Liu,Xueli Yang,Ya-Ting Feng,Gang Chen,Mo Hao
出处
期刊:International Journal of Cardiology [Elsevier]
卷期号:184: 637-644 被引量:128
标识
DOI:10.1016/j.ijcard.2015.03.045
摘要

Abstract Background No nationwide survey on hypertension was conducted in China since 2002. We assessed the prevalence, awareness, treatment, and control of hypertension in mainland China and in various regions using nationwide data from 2003 to 2012. Methods and results We identified studies that reported age- and gender-specific prevalence and/or age-specific awareness, treatment and control of hypertension in representative population samples from 31 provinces, using China National Knowledge Infrastructure, Wanfang and PubMed, supplemented by a manual search of references of retrieved articles. All data were extracted independently by two investigators using a standardized data-collection form. Overall, 265 million adults (145 million men and 120 million women) had hypertension for a prevalence of 26.7% (28.9% among men and 24.5% among women) in 2010. Among hypertensive patients, only 44.6% were aware of their condition, 35.2% were taking antihypertensive medication, and 11.2% achieved adequate blood pressure control. There were substantial geographic variations in the prevalence and control of hypertension. Hypertension prevalence was the highest in east region (32.6%) followed by northeast region (31.8%). Worse still, the control rate among hypertensive people was very poor in southwest (4.8%) and northeast (5.9%) regions. Conclusions Hypertension is highly prevalent in mainland China, with inadequate awareness, treatment, and control of hypertension. Effective strategies are urgently needed in China, especially in the regions with high prevalence and low control.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
在水一方应助hhc采纳,获得10
3秒前
哈哈Hank完成签到,获得积分10
3秒前
3秒前
Jenny完成签到,获得积分10
4秒前
5秒前
5秒前
Serena510完成签到 ,获得积分10
6秒前
xiangqing完成签到 ,获得积分10
7秒前
7秒前
8秒前
SHUAI完成签到,获得积分10
9秒前
岁峰柒完成签到 ,获得积分10
9秒前
郜雨寒发布了新的文献求助10
10秒前
yy发布了新的文献求助10
11秒前
qiqiqiqiqi完成签到 ,获得积分10
11秒前
传统的幻梦完成签到,获得积分10
11秒前
keep1997发布了新的文献求助10
12秒前
要减肥金针菇完成签到,获得积分10
14秒前
缺粥完成签到 ,获得积分10
15秒前
舒适斑马完成签到,获得积分10
17秒前
碳酸芙兰完成签到,获得积分10
21秒前
友好亚男完成签到 ,获得积分10
22秒前
牧羊少年完成签到,获得积分10
24秒前
27秒前
独钓寒江雪完成签到 ,获得积分10
27秒前
风时因絮完成签到,获得积分10
28秒前
29秒前
板凳完成签到 ,获得积分10
33秒前
倔驴发布了新的文献求助10
33秒前
哈哈嘻嘻完成签到,获得积分10
33秒前
风时因絮发布了新的文献求助10
34秒前
xuan完成签到 ,获得积分10
34秒前
格物致知完成签到,获得积分10
37秒前
111完成签到 ,获得积分10
37秒前
小谢完成签到,获得积分10
38秒前
阿紫吖完成签到 ,获得积分10
38秒前
zyb完成签到 ,获得积分10
40秒前
41秒前
高分求助中
Kinetics of the Esterification Between 2-[(4-hydroxybutoxy)carbonyl] Benzoic Acid with 1,4-Butanediol: Tetrabutyl Orthotitanate as Catalyst 1000
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
Rechtsphilosophie 1000
Handbook of Qualitative Cross-Cultural Research Methods 600
Chen Hansheng: China’s Last Romantic Revolutionary 500
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3139375
求助须知:如何正确求助?哪些是违规求助? 2790295
关于积分的说明 7794840
捐赠科研通 2446748
什么是DOI,文献DOI怎么找? 1301351
科研通“疑难数据库(出版商)”最低求助积分说明 626153
版权声明 601141